Disc Medicine (IRON) – Research Analysts’ Recent Ratings Updates
Disc Medicine (NASDAQ: IRON) has recently received a number of price target changes and ratings updates: 10/21/2026 – Disc Medicine had its “buy” rating reaffirmed by Jefferies Financial Group Inc.. They now have a $149.00 price target on the stock. 10/20/2026 – Disc Medicine had its price target raised by Morgan Stanley from $90.00 to […]
22 Oct 15:56 · The Markets Daily